United States, Sept. 9 -- GE HealthCare today announced that StarGuide GX, its new digital 4D CZT SPECT/CT technology, is 510(k) pending with the U.S. Food and Drug Administration (FDA). Building on the system's recent CE Mark, this milestone is a step towards expanding access to advanced molecular imaging technologies in the United States and marks a significant moment in molecular imaging's evolution - aiming to empower clinicians with a high-performance, general purpose scanner to help personalize care across a growing range of nuclear medicine applications and tracers, including the acquisition of alpha emitters.Momentum is growing in nuclear medicine, driven by a developing pipeline of radioligand therapies poised to reshape the field....